Results of the follow-up survey, group 1=CECS (A) and group 2=CECS+MTSS (B); 0=no, 1=yes; average and SD, or count and percentage
| M/F | Age (years) | Follow-up (days) | Active duty yes/no | Less demanding specialty yes/no | Fasciotomy yes/no | Symptoms now yes/no | SANE now | Treatment success yes/no |
| (A) Group 1=CECS | ||||||||
| M | 30 | 1102 | 1 | 0 | 1 | 1 | 70 | 0 |
| M | 21 | 1093 | 0 | n.a. | 0 | 1 | 70 | 0 |
| M | 29 | 701 | 1 | 0 | 1 | 1 | 70 | 0 |
| M | 23 | 511 | 0 | n.a. | 0 | 0 | 70 | 0 |
| F | 25 | 889 | 0 | n.a. | 0 | 1 | 80 | 0 |
| M | 23 | 731 | 0 | n.a. | 0 | 1 | 80 | 0 |
| M | 22 | 625 | 0 | n.a. | 1 | 0 | 90 | 0 |
| M | 22 | 1137 | 1 | 1 | 1 | 0 | 100 | 0 |
| M | 25 | 1098 | 0 | n.a. | 0 | 0 | 100 | 0 |
| M | 19 | 408 | 1 | 0 | 0 | 1 | 50 | 1 |
| M | 22 | 653 | 1 | 0 | 0 | 1 | 75 | 1 |
| F | 23 | 827 | 1 | 0 | 0 | 0 | 80 | 1 |
| M | 19 | 801 | 1 | 1 | 0 | 1 | 80 | 1 |
| M | 24 | 556 | 1 | 0 | 0 | 1 | 80 | 1 |
| F | 23 | 434 | 1 | 0 | 0 | 1 | 80 | 1 |
| M | 21 | 907 | 1 | 0 | 0 | 0 | 85 | 1 |
| M | 25 | 961 | 1 | 0 | 0 | 0 | 100 | 1 |
| M | 21 | 731 | 1 | 1 | 0 | 0 | 100 | 1 |
| M | 23 | 445 | 1 | 0 | 0 | 0 | 100 | 1 |
| M | 21 | 497 | 1 | 0 | 0 | 0 | 100 | 1 |
| n=20 | 23* | 755,4 | 14 | 3 | 4 | 10 | 83,0 | 11 |
| (3,75) | (241,2) | (70%) | 3/14=21% | (20%) | (50%) | (13,9) | (55%) | |
| (B) Group 2= CECS+MTSS | ||||||||
| M | 21 | 1026 | 0 | n.a. | 0 | 1 | 20 | 0 |
| M | 23 | 1030 | 0 | n.a. | 1 | 1 | 40 | 0 |
| F | 19 | 516 | 0 | n.a. | 0 | 1 | 40 | 0 |
| M | 22 | 1088 | 0 | n.a. | 0 | 1 | 60 | 0 |
| M | 22 | 878 | 0 | n.a. | 0 | 1 | 60 | 0 |
| M | 19 | 996 | 0 | n.a. | 0 | 1 | 70 | 0 |
| F | 22 | 1256 | 0 | n.a. | 0 | 0 | 70 | 0 |
| F | 21 | 839 | 0 | n.a. | 0 | 1 | 70 | 0 |
| F | 22 | 381 | 0 | n.a. | 0 | 1 | 80 | 0 |
| F | 20 | 477 | 1 | 0 | 0 | 1 | 30 | 1 |
| F | 24 | 433 | 1 | 0 | 0 | 1 | 75 | 1 |
| M | 31 | 1056 | 1 | 0 | 0 | 0 | 80 | 1 |
| M | 24 | 408 | 1 | 0 | 0 | 0 | 80 | 1 |
| M | 21 | 530 | 1 | 1 | 0 | 0 | 85 | 1 |
| M | 19 | 471 | 1 | 1 | 0 | 0 | 90 | 1 |
| M | 25 | 1173 | 1 | 1 | 0 | 0 | 90 | 1 |
| M | 21 | 381 | 1 | 0 | 0 | 0 | 95 | 1 |
| M | 21 | 520 | 1 | 1 | 0 | 0 | 95 | 1 |
| M | 27 | 526 | 1 | 1 | 0 | 0 | 100 | 1 |
| M | 21 | 462 | 1 | 1 | 0 | 0 | 100 | 1 |
| M | 21 | 764 | 1 | 0 | 0 | 0 | 100 | 1 |
| M | 18 | 839 | 1 | 0 | 0 | 0 | 100 | 1 |
| n=22 | 21* | 729,5 | 13 | 6 | 1 | 10 | 74,1 | 13 |
| (2,5) | (293,8) | (59%) | 6/12=50% | (5%) | (48%) | (23,8) | (59%) | |
Note: in total 42/50 patients were reached (84%). At follow-up: 24/42 patients (57%) were still active duty and without fasciotomy; 18/42 returned to their original military specialty (43%); 15/42 left the military (36%); 20/42 still had symptoms (48%); 5/42 patients received fasciotomy (12%).
*Median and IQR.
CECS, chronic exertional compartment syndrome; F, female; M, male; MTSS, medial tibial stress syndrome; n.a., not applicable; SANE, Single Assessment Numerical Evaluation.